Combined Central Retinal Vein and Cilioretinal Artery Occlusion in the Setting of Intravenous Immunoglobulin Administration.

PubMed ID: 37007171

Author(s): Tsui JC, Crabtree GS. Combined Central Retinal Vein and Cilioretinal Artery Occlusion in the Setting of Intravenous Immunoglobulin Administration. J Vitreoretin Dis. 2021 Mar 24;5(6):546-548. doi: 10.1177/2474126421998600. eCollection 2021 Nov-Dec. PMID 37007171

Journal: Journal Of Vitreoretinal Diseases, Volume 5, Issue 6, 2021

PURPOSE This work reports a case of combined vascular occlusion in the setting of intravenous immunoglobulin (IVIg) administration.

METHODS The authors describe a case of combined central retinal vein and cilioretinal artery that occurred in the setting of IVIg administration.

RESULTS A 52-year-old White man presented with a unilateral subjective scotoma that began during IVIg administered for the treatment of statin-induced necrotizing autoimmune myopathy. Examination and optical coherence tomography imaging revealed a combined nonischemic central retinal vein and cilioretinal artery occlusion.

CONCLUSIONS To the authors’ review and knowledge, this is the first reported case of combined central retinal vein and cilioretinal artery occlusion occurring in the setting of IVIg administration. This rare adverse effect is an entity to be considered in patients who are treated with IVIg.

© The Author(s) 2021.